Michel Farnier

Thoughts on moderate-intensity statin combination therapy vs high-intensity statin monotherapy in clinical practice

Dyslipidemia

Thoughts on moderate-intensity statin combination therapy vs high-intensity statin monotherapy in clinical practice

Watch Prof. Michel Farnier (France) discussing the article "Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING)"